11 Jul 2018 07:00
11 July 2018
Accrol Group Holdings plc
("Accrol" or the "Group")
AIM: ACRL
Â
Notice of Final Results
Â
Accrol, the leading independent tissue converter in the UK, will announce its Final Results for the year ended 30 April 2018 on Wednesday, 26 September 2018, which will include a full update on the progress of the Group's turnaround.
Â
As previously announced, the Board continues to expect that the Group's underlying EBITDA for the year ended 30 April 2018 will be in line with market expectations.
Â
Enquiries:
Accrol Group Holdings plc | Tel: +44 (0) 1254 278 844 |
Dan Wright, Executive Chairman | Â |
Gareth Jenkins, Chief Executive Officer | Â |
Steve Townsley, Chief Financial Officer | Â |
 |  |
Zeus Capital Limited (Nominated Adviser & Broker) |  |
Dan Bate / Andrew Jones | Tel: +44 (0) 161 831 1512 |
Dominic King / John Goold | Tel: +44 (0) 203 829 5000 |
 |  |
Belvedere Communications Limited  | Tel: +44 (0) 203 567 0510 |
Catriona Valentine (cvalentine@belvederepr.com) | Â |
Llewellyn Angus (langus@belvederepr.com) | Â |
Â
Notes to Editors
Â
Accrol Group Holdings plc, based in Lancashire, is a leading tissue converter and supplier of toilet rolls, kitchen rolls and facial tissues, as well as other tissue products, to major discounters and grocery retailers throughout the UK.Â
Â
Accrol operates from three sites:
Â
· A manufacturing, storage and distribution facility in Blackburn;
· A facial tissue plant, also in Blackburn; and
· A manufacturing, storage and distribution facility in Leyland.
Â
Â